Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab. [electronic resource]
- Therapeutic drug monitoring 10 2019
- 634-639 p. digital
Publication Type: Journal Article; Multicenter Study
1536-3694
10.1097/FTD.0000000000000646 doi
Antibody Formation--drug effects Biomarkers--blood Female HLA-C Antigens--blood Humans Male Methotrexate--therapeutic use Middle Aged Netherlands Prospective Studies Psoriasis--blood Severity of Illness Index Treatment Outcome Ustekinumab--therapeutic use